神州细胞股价下跌5.01% 因资金博弈加剧股价震荡

智选洞察2025-08-01

神州细胞股价大幅下跌，最新价71.05元/股，跌幅达5.01%。资金博弈加剧股价震荡近期神州细胞资金流向主要源于资金面剧烈波动。7月25日至30日，单日主力资金流向多次出现超4000万元级别反转，政策利好与估值压力形成双向拉锯。7月初创新药支持政策落地后，生物制品板块获机构加仓超4700万元，但同期股东减持185.79万股引发筹码松动。截至7月30日，公司动态市盈率高达328倍，年内累计涨幅...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2556186947?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-01 13:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2556186947","market":"sh","top_or_hot":-1,"title":"神州细胞股价下跌5.01% 因资金博弈加剧股价震荡","media":"智选洞察","content":"<div>\n<p>神州细胞股价大幅下跌，最新价71.05元/股，跌幅达5.01%。资金博弈加剧股价震荡近期神州细胞资金流向主要源于资金面剧烈波动。7月25日至30日，单日主力资金流向多次出现超4000万元级别反转，政策利好与估值压力形成双向拉锯。7月初创新药支持政策落地后，生物制品板块获机构加仓超4700万元，但同期股东减持185.79万股引发筹码松动。截至7月30日，公司动态市盈率高达328倍，年内累计涨幅...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801130050a6cd024c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>神州细胞股价下跌5.01% 因资金博弈加剧股价震荡</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n神州细胞股价下跌5.01% 因资金博弈加剧股价震荡\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-01 13:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801130050a6cd024c&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>神州细胞股价大幅下跌，最新价71.05元/股，跌幅达5.01%。资金博弈加剧股价震荡近期神州细胞资金流向主要源于资金面剧烈波动。7月25日至30日，单日主力资金流向多次出现超4000万元级别反转，政策利好与估值压力形成双向拉锯。7月初创新药支持政策落地后，生物制品板块获机构加仓超4700万元，但同期股东减持185.79万股引发筹码松动。截至7月30日，公司动态市盈率高达328倍，年内累计涨幅...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801130050a6cd024c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801130050a6cd024c&s=b","article_id":"2556186947","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801130050a6cd024c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2556186947","pubTimestamp":1754024439,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"神州细胞股价大幅下跌，最新价71.05元/股，跌幅达5.01%。资金博弈加剧股价震荡近期神州细胞资金流向主要源于资金面剧烈波动。截至7月30日，公司动态市盈率高达328倍，年内累计涨幅106%促使获利盘集中兑现，融资余额单日骤降4770万元显示杠杆资金加速离场。当前股价回落至71元附近，311倍动态市盈率隐含管线兑现预期，但需警惕临床进展不及预期或政策调整引发的估值重构风险。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688520":"神州细胞","BK0239":"医药制造"},"translate_title":"Shenzhou Cell's stock price fell 5.01% as capital game intensified stock price volatility","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688520":1},"content_text":"神州细胞股价大幅下跌，最新价71.05元/股，跌幅达5.01%。资金博弈加剧股价震荡近期神州细胞资金流向主要源于资金面剧烈波动。7月25日至30日，单日主力资金流向多次出现超4000万元级别反转，政策利好与估值压力形成双向拉锯。7月初创新药支持政策落地后，生物制品板块获机构加仓超4700万元，但同期股东减持185.79万股引发筹码松动。截至7月30日，公司动态市盈率高达328倍，年内累计涨幅106%促使获利盘集中兑现，融资余额单日骤降4770万元显示杠杆资金加速离场。资金在政策预期与高估值修正间反复博弈，成为短期波动的主要推手。管线兑现能力锚定价值中枢中长期股价走势将取决于核心产品的商业化进程。主力产品安佳因2025年前三季度贡献超75%营收，医保谈判后的市场渗透率提升空间成为关键变量。国泰君安研报指出，若SCTB14泛瘤种适应症临床数据超预期，峰值营收或突破50亿元，并给予90元目标价。公司研发投入持续加码，2025年前三季度预计投入5.6亿元布局肿瘤疫苗赛道，子公司SCT640C注射液近期获批类风湿关节炎临床试验。当前股价回落至71元附近，311倍动态市盈率隐含管线兑现预期，但需警惕临床进展不及预期或政策调整引发的估值重构风险。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2556186947","isCrawlerRequest":true}